DaicelDAICEL CORPORATION4202東証プライム化学FY ending Mar 2026, consolidated, J-GAAP

Daicel revenue and profit

Out of every ¥100 of sales, about ¥7 is left as operating profit. Revenue changed -1.2% from the prior year, operating profit -31.0%.

Five-year trend

Revenue¥579.6B
FY ending Mar 2022: ¥467.9B¥467.9BFY ending Mar 2023: ¥538B¥538BFY ending Mar 2024: ¥558.1B¥558.1BFY ending Mar 2025: ¥586.5B¥586.5BFY ending Mar 2026: ¥579.6B¥579.6BFY22FY23FY24FY25FY26
Operating income¥42.1B
FY ending Mar 2022: ¥50.7B¥50.7BFY ending Mar 2023: ¥47.5B¥47.5BFY ending Mar 2024: ¥62.4B¥62.4BFY ending Mar 2025: ¥61B¥61BFY ending Mar 2026: ¥42.1B¥42.1BFY22FY23FY24FY25FY26
Operating margin7.3%
FY ending Mar 2022: 10.8%10.8%FY ending Mar 2023: 8.8%8.8%FY ending Mar 2024: 11.2%11.2%FY ending Mar 2025: 10.4%10.4%FY ending Mar 2026: 7.3%7.3%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin1.8%
Asset turnover0.70×
ROA1.2%
ROA1.2%
Financial leverage3.12×
ROE3.9%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin1.8%
2022: 6.7%6.7%2023: 7.6%7.6%2024: 10.0%10.0%2025: 8.4%8.4%2026: 1.8%1.8%2223242526
Asset turnover0.70×
2022: 0.67×0.67×2023: 0.73×0.73×2024: 0.70×0.70×2025: 0.71×0.71×2026: 0.70×0.70×2223242526
ROA1.2%
2022: 4.5%4.5%2023: 5.6%5.6%2024: 7.0%7.0%2025: 6.0%6.0%2026: 1.2%1.2%2223242526
Financial leverage3.12×
2022: 3.41×3.41×2023: 3.41×3.41×2024: 3.35×3.35×2025: 3.13×3.13×2026: 3.12×3.12×2223242526
ROE3.9%
2022: 15.3%15.3%2023: 18.9%18.9%2024: 23.3%23.3%2025: 18.7%18.7%2026: 3.9%3.9%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20226.7%0.67×4.5%3.41×15.3%
20237.6%0.73×5.6%3.41×18.9%
202410.0%0.70×7.0%3.35×23.3%
20258.4%0.71×6.0%3.13×18.7%
20261.8%0.70×1.2%3.12×3.9%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue57.7%
2021: 55.8%55.8%2022: 49.1%49.1%2023: 47.6%47.6%2024: 55.4%55.4%2025: 54.5%54.5%2026: 57.7%57.7%212223242526
PPE ÷ total assets40.1%
2021: 34.3%34.3%2022: 32.9%32.9%2023: 33.5%33.5%2024: 36.8%36.8%2025: 39.2%39.2%2026: 40.1%40.1%212223242526
Goodwill ÷ parent equity0.0%
2021: 1.3%1.3%2022: 0.2%0.2%2023: 0.2%0.2%2024: 0.0%0.0%2025: 0.0%0.0%2026: 0.0%0.0%212223242526
Goodwill balance¥52M
2021: ¥2.41B¥2.41B2022: ¥363M¥363M2023: ¥338M¥338M2024: ¥85M¥85M2025: ¥66M¥66M2026: ¥52M¥52M212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥25.6B
2021: ¥19.5B¥19.5B2022: ¥20.7B¥20.7B2023: ¥21.9B¥21.9B2024: ¥23.4B¥23.4B2025: ¥25.9B¥25.9B2026: ¥25.6B¥25.6B212223242526
R&D / revenue4.4%
2021: 5.0%5.0%2022: 4.4%4.4%2023: 4.1%4.1%2024: 4.2%4.2%2025: 4.4%4.4%2026: 4.4%4.4%212223242526
Cash conversion cycle—
2021: 163d163d212223242526
Receivable days—
2021: 86d86d212223242526
Inventory days147d
2021: 141d141d2022: 157d157d2023: 165d165d2024: 167d167d2025: 154d154d2026: 147d147d212223242526
Payable days51d
2021: 64d64d2022: 69d69d2023: 52d52d2024: 57d57d2025: 53d53d2026: 51d51d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue467,937538,026558,056586,531579,629
Cost of revenue329,329392,214398,776421,785433,340
Gross profit138,607145,811159,280164,746146,288
SG&A87,91098,30396,887103,735104,219
Operating income50,69747,50862,39361,01142,069
Pretax income46,28354,96776,03265,49926,169
Income tax14,22913,32619,48715,02214,722
Net income attributable to owners31,25440,68255,83449,48010,180
Operating margin10.8%8.8%11.2%10.4%7.3%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

8%
Inventories 21%
Property, plant and equipment 40%
1%
6%
Other assets 24%

Funding

7%
Interest-bearing debt 35%
Other liabilities 14%
Equity 44%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥88B¥93.5B¥68.4B¥64.8B¥66.8B
Total assets¥698.8B¥765.6B¥839.2B¥813.8B¥833.9B
Net assets¥279.5B¥310.4B¥375.4B¥375B¥370.4B
Share capital¥36.3B¥36.3B¥36.3B¥36.3B¥36.3B
Inventories¥142B¥177.2B¥182.5B¥177.9B¥174.5B
Property, plant and equipment¥229.8B¥256.1B¥308.9B¥319.4B¥334.4B
Intangible assets excluding goodwill¥10.1B¥11.2B¥10.8B¥10.6B¥11.1B
Goodwill¥363M¥338M¥85M¥66M¥52M
Investment securities¥73.2B¥67.9B¥80B¥56.7B¥45.5B
Current assets¥360.2B¥406.6B¥409.5B¥395.6B¥403.2B
Current liabilities¥153.9B¥220.9B¥208.8B¥210.4B¥197.6B
Trade payables¥61.9B¥56.2B¥62.2B¥61.2B¥60.4B
Short-term borrowings¥22.2B¥36.3B¥31.8B¥35.9B¥50.1B
Long-term borrowings¥106B¥108.8B¥124.7B¥138B¥170B
Bonds¥130B¥100B¥90B¥70B¥70B
Interest-bearing debt¥258.2Bderived¥245.1Bderived¥246.5Bderived¥243.9Bderived¥290.1Bderived
Total liabilities¥419.3B¥455.2B¥463.8B¥438.8B¥463.5B
Non-controlling interests¥7.53B¥15.2B¥16B¥15.1B¥14.8B
Equity attributable to owners of parent¥204.7B¥225.2B¥254B¥273.8B¥254.8B
Retained earnings¥174.5B¥204.5B¥233.7B¥253.7B¥234.3B
Treasury stock-¥6.09B-¥15.7B-¥15.9B-¥16.2B-¥15.7B

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第160期(2025/04/01-2026/03/31)

    ID S100YBO02026-06-17Open
  • EDINET (FSA Japan)

    有価証券報告書-第159期(2024/04/01-2025/03/31)

    ID S100VYQ92025-06-18Open
  • EDINET (FSA Japan)

    有価証券報告書-第158期(2023/04/01-2024/03/31)

    ID S100TPVN2024-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第157期(2022/04/01-2023/03/31)

    ID S100R12O2023-06-26Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第156期(令和3年4月1日-令和4年3月31日)

    ID S100OOJW2022-07-07Open
  • EDINET (FSA Japan)

    有価証券報告書-第155期(令和2年4月1日-令和3年3月31日)

    ID S100LS802021-06-28Open

Extracted from XBRL: 56 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.